HHS建议禁止联邦资助对未成年人进行性别确认护理,提出安全关切,并与最近的一项行政命令保持一致。 HHS proposes banning federal funding for gender-affirming care for minors, citing safety concerns and aligning with a recent executive order.

卫生和公众服务部提出了限制对未成年人进行性别确认治疗的新规则,包括激素疗法、青春期阻塞器和外科手术,并列举了健康风险和缺乏经证实的好处。 The Department of Health and Human Services has proposed new rules restricting gender-affirming treatments for minors, including hormone therapy, puberty blockers, and surgeries, citing health risks and lack of proven benefits. 接受联邦资金的医院如果提供这些治疗,就会失去支助,而且医疗补助、医疗保险和CHIP将被禁止为19岁以下的人提供保险。 Hospitals receiving federal funds would lose support if they provide these treatments, and Medicaid, Medicare, and CHIP would be barred from covering them for those under 19. FDA向12家公司发出警告信，指控他们非法销售用于性别焦虑的乳房束胸器。 The FDA issued warning letters to 12 companies for illegally marketing breast binders for gender dysphoria. HHS还计划重新定义残疾,除与身体状况有关的残疾外,排除性别发育不良症。 HHS also plans to redefine disability to exclude gender dysphoria unless tied to a physical condition. 这项行动符合2025年1月禁止此类程序的一项行政命令,HHS秘书Robert F. Kennedy Jr.称这些程序危险,类似于渎职行为。 The move aligns with a January 2025 executive order banning such procedures, with HHS Secretary Robert F. Kennedy Jr. calling them dangerous and akin to malpractice.